XBiotech Inc (NASDAQ:XBIT)
| 14.07 Delayed Data As of Feb 21 |  -0.23 / -1.61%Today’s Change | 6.76 Today|||52-Week Range 26.40 | -24.62% Year-to-Date |
Latest XBIT News | Press Releases
| Why XBiotech Shares Are Tumbling 23.4% Today Feb 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 14.30 |
| Today’s open | 14.17 |
| Day’s range | 13.83 - 14.56 |
| Volume | 1,528,161 |
| Average volume (3 months) | 653,722 |
| Market cap | $578.1M |
Data as of 4:00pm ET, 02/21/2020
Growth & Valuation
| Earnings growth (last year) | +37.85% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 12.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRVLPrevail Therapeutics... | -0.03 | -0.18% |
| NKNantKwest Inc | -0.21 | -3.52% |
| REPLReplimune Group Inc | -0.27 | -1.60% |
| MRUSMerus NV | -0.20 | -1.04% |
Data as of 4:00pm ET, 02/21/2020
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$21.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
